How the Trump Administration Could Impact Research
Federal Relations’ Jennifer Grodsky on the uncertainties ahead for BU There are a lot of unknowns about the impact the incoming Trump administration and the new Congress will have on federally funded research at BU and other universities. Photo by Kkolosov/iStock. As Donald Trump assumes the presidency, Boston University and other higher education institutions face […]
A Better Way to Treat Burns from BU’s Grinstaff Lab
Less painful for patients, eliminates need for anesthetizing children Mark Grinstaff and members of his lab, among them Marlena Konieczynska, have developed a new hydrogen gel that could eliminate the need to anesthetize children for burn dressing changes. Photo by Jackie Ricciardi. For patients with second-degree burns, it’s not always the initial injury that hurts […]
New Targets to Treat Type 1 Diabetes
Chemist Arturo Vegas wins $1.4 million NIH grant to develop therapies that intervene at early stage of disease Arturo Vegas wants to create novel therapies that will either suppress rogue immune cells attacking the pancreas of people with type 1 diabetes or strengthen the pancreas’ defenses against the rogue cells. Photo courtesy of Arturo Vegas. […]
Bucking Trends, BU Outside Funding Continues to Rise
Team behind the scenes keeps the money coming in Amy Lieberman, an SED assistant professor of deaf studies, says BU “made it clear that my research was going to be valued and supported here. It’s a big part of the reason I came.” Photo by Cydney Scott. The chart of United States R&D funding, as […]
Hospitals Cut Readmissions, But at What Cost?
Critics say Medicare program penalizes safety-net hospitals Report says that safety-net hospitals should be compared to other safety-net hospitals, rather than put into one broad category. Photo by EunikaSopotnicka/iStock. Safety-net hospitals, which serve large populations of low-income patients, have made significant progress in reducing patient readmissions under a federal penalty program, but adjustments to the […]
Alzheimer’s Start-up Gets $1.49 Million from NIH
Collaboration between MED prof, husband Carmela and Menachem Abraham collaborated on a start-up to develop novel therapeutics for Alzheimer’s disease. Klogene Therapeutics, Inc., recently won a $1.49 million grant from the National Institutes of Health. Photo by Jackie Ricciardi. Carmela Abraham came home one day three years ago from her BU lab, where she has […]
New Tool to Diagnose Zika
BU researcher on team that created prototype for simple new test Dana Braff (ENG’17), one of the lead authors on a Cell paper that describes a prototype for a new Zika diagnostic (photo above). Zika grabbed the world’s attention in late 2015, when scientists in Brazil began to suspect a connection between the virus and […]
CTE Investigators Launch $16 Million Study
A former football player describes brain disease symptoms and angst Tim Fox, the 62-year-old former New England Patriots safety, was describing to a room full of brain scientists at the Boston University School of Medicine (MED) the ferocious style of play that he’d been trained in from an early age, one that had led to […]
Sandro Galea’s Vision for Public Health
SPH dean emphasizes social justice issues like race, poverty Sandro Galea switched careers after a stint with Doctors Without Borders, leaving the immediate gratification of medicine to labor in the vineyard of public health. Photo By Eric Levin. Sandro Galea stood with his backpack at the edge of a small airstrip in Mendi, Papua New […]
Unraveling Alzheimer’s Disease
Alzheimer’s disease is an epidemic. It attacks the brain’s nerve cells, causing memory loss, behavioral changes, confusion, and deterioration of language skills. It affects more than five million Americans 65 and older, and that is expected to increase to 13.8 million by 2050 unless science finds a treatment. Alzheimer’s and other forms of dementia are […]